Clinical Trials at University of Texas Southwestern
As of September 2026, 57 paid clinical trials are recruiting at University of Texas Southwestern, located at UTSW DEPARTMENT OF PSYCHIATRY, 5323 HARRY HINES BLVD, SUITE NC5.804, DALLAS, TX 75390-0001, phone (214) 648-7012 in Dallas, Texas. Active studies at this site cover conditions such as Heart Failure, Breast Cancer and Obesity. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Dallas
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
58 clinical trials at University of Texas Southwestern
·Clear filters·FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
US National OCS Heart Perfusion (OHP) Registry
A Gaucher Disease Gene Therapy Trial With FLT201
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
A Study of ASP1002 in Adults for Treatment of Solid Tumors
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
STRIVE Post-Market Registry Study
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Study of SGR-1505 in Mature B-Cell Neoplasms
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
Study of SGR-3515 In Participants With Advanced Solid Tumors.
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
SPI-1005 in Adults Receiving Cochlear Implant
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Once Weekly Infant Corticosteroid Trial for DMD
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Predicting BCG Response
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Cerebellar tDCS in Children With Autism Spectrum Disorder
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Common conditions studied in Dallas
- Heart Failure (33 active studies)
- Breast Cancer (30 active studies)
- Obesity (26 active studies)
- Prostate Cancer (20 active studies)
- Advanced Solid Tumor (18 active studies)
- Overweight (18 active studies)
Leading research sponsors in Dallas
- University of Texas Southwestern Medical Center
- Eli Lilly and Company
- Baylor Research Institute
- AstraZeneca
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Dallas?
There are approximately 1,565 recruiting clinical trials in Dallas, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Dallas pay participants?
Most recruiting trials in Dallas compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Dallas?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Dallas?
The most common conditions under active study in Dallas include Heart Failure (33), Breast Cancer (30), Obesity (26), Prostate Cancer (20), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Dallas?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Dallas on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Dallas?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Dallas?
Recruiting research sites in Dallas include University of Texas Southwestern Medical Center, UT Southwestern Medical Center, UT Southwestern/Simmons Cancer Center-Dallas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Dallas right now?
The largest active categories in Dallas are Cancer & tumors (426), Cardiovascular (130), Neurology & pain (79). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Texas Southwestern?
University of Texas Southwestern is located at UTSW DEPARTMENT OF PSYCHIATRY, 5323 HARRY HINES BLVD, SUITE NC5.804, DALLAS, TX 75390-0001. Use the Google Maps link in the intro above to get directions.
How do I contact University of Texas Southwestern?
You can reach University of Texas Southwestern by phone at (214) 648-7012. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.